Expertise in
12
conditions

Klaus K. Herfarth

Heidelberg, BW, DE 
Expertise in
12
conditions
Heidelberg, BW, DE 

Overview

Klaus Herfarth practices practicing medicine in Heidelberg, Germany.

Mr. Herfarth is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Chordoma, Follicular Lymphoma, Laryngectomy, and Thymectomy.

He is actively involved in clinical research, co-authoring 201 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Heidelberg, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Hypofractionated Ion Irradiation (Protons or Carbon Ions) of Sacrococcygeal Chordoma
Hypofractionated Ion Irradiation (Protons or Carbon Ions) of Sacrococcygeal Chordoma
Enrollment Status: Unknown
Publish Date: December 06, 2023
Intervention Type: Radiation
Study Phase: Phase 2
Evaluation of Inter- and Intrafractional Motion of Liver Tumors Using Interstitial Markers and Implantable Electro-magnetic Radiotransmitters in the Context of Image-guided Radiotherapy (IGRT) - the ESMERALDA Trial
Evaluation of Inter- and Intrafractional Motion of Liver Tumors Using Interstitial Markers and Implantable Electro-magnetic Radiotransmitters in the Context of Image-guided Radiotherapy (IGRT) - the ESMERALDA Trial
Enrollment Status: Withdrawn
Publish Date: May 17, 2018
Intervention Type: Behavioral
Study Phase: Not Applicable
View 1 Less Clinical Trial

201 Total Publications

Correction to: DEGRO consensus framework for undergraduate radiation therapy teaching in Germany: a white paper with integrated guidance on artificial intelligence in medical education.
Correction to: DEGRO consensus framework for undergraduate radiation therapy teaching in Germany: a white paper with integrated guidance on artificial intelligence in medical education.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: September 04, 2026

Frequently Asked Questions about Klaus K. Herfarth

Is Klaus K. Herfarth a top-rated expert for Adenoid Cystic Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Klaus K. Herfarth is classified as an Distinguished expert for Adenoid Cystic Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Klaus K. Herfarth participate in research or clinical trials?

Yes. Klaus K. Herfarth has published 201 articles and abstracts on conditions like Adenoid Cystic Carcinoma. You can view a list of Klaus K. Herfarth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Herfarth's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile